Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy
Z Sasson,
PG Yock,
LK Hatle,
EL Alderman,
and
RL Popp
Cardiology Division, Stanford University School of Medicine, California.
The continuous wave Doppler ultrasound signal across the left ventricular outflow tract in hypertrophic cardiomyopathy has a characteristic pattern that is in keeping with the dynamic nature of the pressure gradient in this condition. To determine the accuracy and reliability of the peak Doppler flow velocity signal for measuring the peak pressure gradient in this condition, 340 beats were analyzed from five consecutive patients studied with simultaneous continuous wave Doppler ultrasound and dual catheter pressure recordings across the left ventricular outflow tract. Each patient was studied at steady state and during physiologic and pharmacologic manipulations of the pressure gradient. Peak velocity and calculated peak gradient were determined by two independent observers who did not know the catheter measurements. In addition, 18 beats with well defined flow velocity envelopes were digitized for analysis of the magnitude, timing and contour of the instantaneous Doppler ultrasound and catheter gradients throughout systole. Peak catheter gradient in the 340 beats ranged from 12 to 245 mm Hg. The correlations between the Doppler-derived and catheter peak gradients were close (r = 0.96, SEE = 4 mm Hg for Observer 1 and r = 0.97, SEE = 11 mm Hg for Observer 2). Interobserver variability for measurement of peak flow velocity was small (mean +/- SD 0.16 +/- 0.15 m/s). An interobserver difference greater than 0.3 m/s occurred in 25 of the 340 beats analyzed. By retrospective analysis, this was due to contamination of the outflow tract signal by mitral regurgitation.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
|
|
 
B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, H. Rakowski, et al.
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
December 13, 2011;
58(25):
2703 - 2738.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, H. Rakowski, et al.
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
December 13, 2011;
58(25):
e212 - e260.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, et al.
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
December 13, 2011;
124(24):
e783 - e831.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, et al.
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
December 13, 2011;
124(24):
2761 - 2796.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members:*, B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, et al.
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
J. Thorac. Cardiovasc. Surg.,
December 1, 2011;
142(6):
1303 - 1338.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members:*, B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, et al.
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
J. Thorac. Cardiovasc. Surg.,
December 1, 2011;
142(6):
e153 - e203.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Ball, J. Ivanov, H. Rakowski, E. D. Wigle, M. Linghorne, A. Ralph-Edwards, W. G. Williams, L. Schwartz, A. Guttman, and A. Woo
Long-Term Survival in Patients With Resting Obstructive Hypertrophic Cardiomyopathy: Comparison of Conservative Versus Invasive Treatment
J. Am. Coll. Cardiol.,
November 22, 2011;
58(22):
2313 - 2321.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. Hwang, E.-Y. Choi, J. Kwan, S. A. Kim, C. Y. Shim, J.-W. Ha, S.-J. Rim, N. Chung, and S. S. Kim
Dynamic change of mitral apparatus as potential cause of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
Eur Heart J Cardiovasc Imaging,
January 1, 2011;
12(1):
19 - 25.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sommer, S. H. Poulsen, J. Mogensen, L. Thuesen, and H. Egeblad
Left ventricular longitudinal systolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a long-term follow-up study focused on speckle tracking echocardiography
Eur Heart J Cardiovasc Imaging,
December 1, 2010;
11(10):
883 - 888.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.-H. Kim, M. D. Handschumacher, R. A. Levine, Y.-S. Choi, Y. J. Kim, S.-C. Yun, J.-M. Song, D.-H. Kang, and J.-K. Song
In Vivo Measurement of Mitral Leaflet Surface Area and Subvalvular Geometry in Patients With Asymmetrical Septal Hypertrophy: Insights Into the Mechanism of Outflow Tract Obstruction
Circulation,
September 28, 2010;
122(13):
1298 - 1307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cikes, H. Kalinic, A. Baltabaeva, S. Loncaric, C. Parsai, D. Milicic, I. Cikes, G. Sutherland, and B. Bijnens
The shape of the aortic outflow velocity profile revisited: is there a relation between its asymmetry and ventricular function in coronary artery disease?
Eur Heart J Cardiovasc Imaging,
October 1, 2009;
10(7):
847 - 857.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. C. Afonso, J. Bernal, J. J. Bax, and T. P. Abraham
Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies.
J. Am. Coll. Cardiol. Img.,
November 1, 2008;
1(6):
787 - 800.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D H Kwon, R M Setser, M Thamilarasan, Z V Popovic, N G Smedira, P Schoenhagen, M J Garcia, H M Lever, and M Y Desai
Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
Heart,
October 1, 2008;
94(10):
1295 - 1301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. K. Kaple, R. T. Murphy, L. M. DiPaola, P. L. Houghtaling, H. M. Lever, B. W. Lytle, E. H. Blackstone, and N. G. Smedira
Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes
Ann. Thorac. Surg.,
May 1, 2008;
85(5):
1527 - 1535.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. I I Soliman, P. Knaapen, M. L Geleijnse, P. A Dijkmans, A. M Anwar, A. Nemes, M. Michels, W. B Vletter, A. A Lammertsma, and F. J ten Cate
Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography
Heart,
October 1, 2007;
93(10):
1204 - 1212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Barac, S. Upadya, R. Pilchik, G. Winson, M. Passick, F. A. Chaudhry, and M. V. Sherrid
Effect of Obstruction on Longitudinal Left Ventricular Shortening in Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol.,
March 20, 2007;
49(11):
1203 - 1211.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Matsuki, K. Isoda, R. Horai, A. Nakajima, Y. Aizawa, K. Suzuki, F. Ohsuzu, and Y. Iwakura
Involvement of Tumor Necrosis Factor-{alpha} in the Development of T Cell-Dependent Aortitis in Interleukin-1 Receptor Antagonist-Deficient Mice
Circulation,
August 30, 2005;
112(9):
1323 - 1331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Woo, W. G. Williams, R. Choi, E. D. Wigle, E. Rozenblyum, K. Fedwick, S. Siu, A. Ralph-Edwards, and H. Rakowski
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
Circulation,
April 26, 2005;
111(16):
2033 - 2041.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. V. Sherrid, I. Barac, W. J. McKenna, P. M. Elliott, S. Dickie, L. Chojnowska, S. Casey, and B. J. Maron
Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
April 19, 2005;
45(8):
1251 - 1258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hamada, Y. Shigematsu, K. Ohshima, J. Suzuki, A. Ogimoto, T. Ohtsuka, and Y. Hara
Diagnostic Usefulness of Carotid Pulse Tracing in Patients With Hypertrophic Obstructive Cardiomyopathy Due to Midventricular Obstruction: A Comparison With Idiopathic Hypertrophic Subaortic Stenosis
Chest,
October 1, 2003;
124(4):
1275 - 1283.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. X. Qin, T. Shiota, H. M. Lever, D. N. Rubin, F. Bauer, Y. J. Kim, M. Sitges, N. L. Greenberg, J. K. Drinko, M. Martin, et al.
Impact of left ventricular outflow tract area on systolic outflow velocity in hypertrophic cardiomyopathy: A real-time three-dimensional echocardiographic study
J. Am. Coll. Cardiol.,
January 16, 2002;
39(2):
308 - 314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Xin, T. Shiota, H. M. Lever, S. R. Kapadia, M. Sitges, D. N. Rubin, F. Bauer, N. L. Greenberg, D. A. Agler, J. K. Drinko, et al.
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
J. Am. Coll. Cardiol.,
December 1, 2001;
38(7):
1994 - 2000.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. F. Nagueh, S. R. Ommen, N. M. Lakkis, D. Killip, W. A. Zoghbi, H. V. Schaff, G. K. Danielson, M. A. Quinones, A. J. Tajik, and W. H. Spencer III
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol.,
November 15, 2001;
38(6):
1701 - 1706.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. F. Nagueh, S. J. Stetson, N. M. Lakkis, D. Killip, A. Perez-Verdia, M. L. Entman, W. H. Spencer III, and G. Torre-Amione
Decreased Expression of Tumor Necrosis Factor-{{alpha}} and Regression of Hypertrophy After Nonsurgical Septal Reduction Therapy for Patients With Hypertrophic Obstructive Cardiomyopathy
Circulation,
April 10, 2001;
103(14):
1844 - 1850.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Mazur, S. F. Nagueh, N. M. Lakkis, K. J. Middleton, D. Killip, R. Roberts, and W. H. Spencer III
Regression of Left Ventricular Hypertrophy After Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
Circulation,
March 20, 2001;
103(11):
1492 - 1496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Flores-Ramirez, N. M. Lakkis, K. J. Middleton, D. Killip, W. H. Spencer III, and S. F. Nagueh
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol.,
January 1, 2001;
37(1):
208 - 214.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. H. C. Yu, A. S. Omran, E. D. Wigle, W. G. Williams, S. C. Siu, and H. Rakowski
Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2219 - 2225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. V. Sherrid, D. Z. Gunsburg, S. Moldenhauer, and G. Pearle
Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
October 1, 2000;
36(4):
1344 - 1354.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. F. Nagueh, N. M. Lakkis, K. J. Middleton, D. Killip, W. A. Zoghbi, M. A. Quinones, and W. H. Spencer III
Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol.,
October 1, 1999;
34(4):
1123 - 1128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Kass, C.-H. Chen, M. W. Talbot, C. E. Rochitte, J. A. C. Lima, R. D. Berger, and H. Calkins
Ventricular Pacing With Premature Excitation for Treatment of Hypertensive-Cardiac Hypertrophy With Cavity-Obliteration
Circulation,
August 24, 1999;
100(8):
807 - 812.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Ommen, R. A. Nishimura, R. W. Squires, H. V. Schaff, G. K. Danielson, and A. J. Tajik
Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points
J. Am. Coll. Cardiol.,
July 1, 1999;
34(1):
191 - 196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Spirito, C. Rapezzi, P. Bellone, S. Betocchi, C. Autore, M. R. Conte, G. P. Bezante, and P. Bruzzi
Infective Endocarditis in Hypertrophic Cardiomyopathy : Prevalence, Incidence, and Indications for Antibiotic Prophylaxis
Circulation,
April 27, 1999;
99(16):
2132 - 2137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. F. Nagueh, N. M. Lakkis, K. J. Middleton, D. Killip, W. A. Zoghbi, M. A. Quinones, and W. H. Spencer
Changes in Left Ventricular Diastolic Function 6 Months After Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
Circulation,
January 26, 1999;
99(3):
344 - 347.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Murgo
Systolic ejection murmurs in the era of modern cardiology: What do we really know?
J. Am. Coll. Cardiol.,
November 15, 1998;
32(6):
1596 - 1602.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. M. Lakkis, S. F. Nagueh, N. S. Kleiman, D. Killip, Z.-X. He, M. S. Verani, R. Roberts, and W. H. Spencer III
Echocardiography-Guided Ethanol Septal Reduction for Hypertrophic Obstructive Cardiomyopathy
Circulation,
October 27, 1998;
98(17):
1750 - 1755.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. F. Nagueh, N. M. Lakkis, Z.-X. He, K. J. Middleton, D. Killip, W. A. Zoghbi, M. A. Quinones, R. Roberts, M. S. Verani, N. S. Kleiman, et al.
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol.,
July 1, 1998;
32(1):
225 - 229.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Kizilbash, S. K. Heinle, and P. A. Grayburn
Spontaneous Variability of Left Ventricular Outflow Tract Gradient in Hypertrophic Obstructive Cardiomyopathy
Circulation,
February 10, 1998;
97(5):
461 - 466.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. V. Sherrid, G. Pearle, and D. Z. Gunsburg
Mechanism of Benefit of Negative Inotropes in Obstructive Hypertrophic Cardiomyopathy
Circulation,
January 13, 1998;
97(1):
41 - 47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hamada, Y. Shigematsu, S. Ikeda, Y. Hara, H. Okayama, K. Kodama, T. Ochi, and K. Hiwada
Class Ia Antiarrhythmic Drug Cibenzoline : A New Approach to the Medical Treatment of Hypertrophic Obstructive Cardiomyopathy
Circulation,
September 2, 1997;
96(5):
1520 - 1524.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. Bartunek, S. U. Sys, A. C. Rodrigues, E. Van Schuerbeeck, L. Mortier, and B. de Bruyne
Abnormal Systolic Intraventricular Flow Velocities After Valve Replacement for Aortic Stenosis : Mechanisms, Predictive Factors, and Prognostic Significance
Circulation,
February 15, 1996;
93(4):
712 - 719.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. R. Fox, S.-K. Liu, and B. J. Maron
Echocardiographic Assessment of Spontaneously Occurring Feline Hypertrophic Cardiomyopathy : An Animal Model of Human Disease
Circulation,
November 1, 1995;
92(9):
2645 - 2651.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. A. Levine, G. J. Vlahakes, X. Lefebvre, J. L. Guerrero, E. G. Cape, A. P. Yoganathan, and A. E. Weyman
Papillary Muscle Displacement Causes Systolic Anterior Motion of the Mitral Valve : Experimental Validation and Insights Into the Mechanism of Subaortic Obstruction
Circulation,
February 15, 1995;
91(4):
1189 - 1195.
[Abstract]
[Full Text]
|
|
|
|
